1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Demographic, clinical, and MRI characteristics of patients with cortical lesions at the study entry
Pt # Age Gender Years of MS EDSS MS type T1 Les Volume (cm³) T2 Les Volume (cm³) CELs BPF CLs(A) CLs(B)
1 35.2 Male 9 5.5 SP 4.4 12.5 0 0.77 0 2
2 35.7 Male 3.4 0 RR 0.8 19.2 6 0.78 1 6
3 35.8 Male 4.7 1.5 RR 1.4 12.1 0 0.78 3 7
4 36.9 Female 15.4 2.5 RR 1.6 16.9 NA 0.81 1 7
5 50.3 Female 8.9 6 SP 2.4 15.2 4 0.82 0 10
6 48.6 Female 24 2.5 RR 4.1 42.2 2 0.77 2 3
7 42.7 Female 0.3 1.5 RR 0.1 2.6 1 0.82 0 3
8 41.2 Female 25.2 4.5 SP 1.2 18.6 1 0.77 1 5
9 48.3 Female 6.1 2.5 SP^* 2.5 68.3 26 0.76 5 1
10 26.5 Female 13 6 SP 7.5 25.6 0 0.76 2 0
11 56.6 Female 18.9 6.5 SP 1.4 6.3 2 0.68 1 7
12 22.3 Male 2 3 RR 4.2 44.70 3 0.81 4 13
13 35.7 Female 11.9 5 SP 0.2 1.2 0 0.82 0 2
Note:—MS indicates multiple sclerosis; RR, relapsing-remitting; SP, secondary-progressive; EDSS, expanded disability status scale; CEL, contrast-enhancing lesion; CL, cortical lesion; BPF, brain parenchymal fraction; NA, not available; Les, lesion.
* Relapsing-progressive MS.